ThompsonAJBanwellBLBarkhofFet al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17: 162–173.
2.
BrownleeWAltmannDAlvesDaMotaPet al. Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome. Mult Scler J2017; 23: 665–674.
3.
BotJCJBlezerELAKamphorstWet al. The spinal cord in multiple sclerosis: Relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology2004; 233: 531–540.
4.
LublinFDReingoldSCCohenJet al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology2014; 83: 278–286.
5.
WattjesMPRoviraÀMillerDet al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis – Establishing disease prognosis and monitoring patients. Nat Rev Neurol2015; 11: 597–606.
PetrovaNCarassitiDAltmannDRet al. Axonal loss in the multiple sclerosis spinal cord revisited. Brain Pathol. Epub ahead of print 7 May 2017. DOI: 10.1111/bpa.12516.
8.
SchlaegerRPapinuttoNPanaraVet al. Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Ann Neurol2014; 76: 568–580.
9.
StromanPWWheeler-KingshottCBaconMet al. The current state-of-the-art of spinal cord imaging: Methods. Neuroimage2014; 84: 1070–1081.
10.
GrussuFSchneiderTTurCet al. Neurite dispersion: A new marker of multiple sclerosis spinal cord pathology?Ann Clin Transl Neurol2017; 4: 663–679.